Editorial Board

    Liew Kai Bin
    Associate Professor
    Pharmaceutical Technology and Industry
    University of Cyberjaya
    Malaysia
    liewkaia@yahoo.com
    IJPSDR

    AP. Ts. Dr. Liew Kai Bin is the head of department of Pharmaceutical Technology and Industry, Faculty of Pharmacy, University of Cyberjaya (UoC). He obtained his Bachelor’s degree in Pharmacy, Master in Science (Pharmaceutical Technology), and Doctor of Philosophy (Pharmaceutical Technology) from Universiti Sains Malaysia (USM). He served as community and industrial pharmacist prior to joining the academia. He has experience in various pharmaceutical related fields including research and development, product development, bioequivalence study, analytical chemistry, regulatory affair and public health pharmacy. He constantly engages in the development of pharmaceutical and traditional medicine industries in the country. Dr Liew is also a registered professional technologist with the Malaysian Board of Technologist.

     He has published more than 80 publications in international journals and books chapter. He was awarded national and international grants that worth more than RM 500k. He has been repeatedly invited as speaker to deliver speeches in various countries such as Japan, India and Indonesia. He has also supervised research projects for both undergraduate and postgraduate pharmacy students. Dr Liew’s research product has won several outstanding, best innovation, gold and silver awards in international exhibitions including Malaysia Technology Expo and International Innovation and Technology Expo.
     Apart from teaching and doing research, he is also actively involved in community service and professional development programmes. He was the counselor in public health campaigns organised by the pharmacy students. He was the organising chairman for a few international workshops and seminars during his tenure in UCSI University. He was also awarded as the Best New Lecturer by UCSI University in 2015.

     Research Interest: Nano formulations, micelle, orally disintegrating tablet, orally disintegrating film, cosmeceuticals, anti-cancer

    More Info.
    Sevil Mehraliyeva Jabrayil
    Head of Pharmaceutical Technology Research Laboratory, Associate Professor, PhD in Pharmacy
    Pharmaceutical Technology and Management
    Azerbaijan Medical University
    Azerbaijan
    sevil66@mail.ru
    IJPSDR

    Mehraliyeva Sevil Jabrayil graduated from the Faculty of Pharmacy of Azerbaijan State Medical Institute named after N.Narimanov in 1989 with honors diploma. was elected to the position and is currently working in this position.

     In 2010, S.J.Mehraliyeva defended her dissertation on the topic "Development of the technology for obtaining medicinal forms from some multicomponent plant assemblies and studying their biopharmaceutical properties", in 2011 she received the diploma of Doctor of Philosophy in Pharmacy, and in 2014 she received the scientific title of associate professor.

     Sevil Mehraliyeva is a member of the "Problem Commission on Pharmacy and Chemistry", 224156-Specialized Council for master's defense in "Pharmaceutical technology". He participated in the congresses held in 2020-2022, including training on Good Clinical Practice and received a certificate. In February 2022, he completed an internship at DAYTAM, Atatürk University of the Republic of Turkey.

    Sevil Mehraliyeva made oral presentations at conferences held in the Republics of Azerbaijan, Russia, and Turkey during the period of her scientific research and was awarded certificates.

    For the first time, Sevil Mehraliyeva developed immunotropic granules based on various phytocompositions, dental gel with anti-aging effect, anti-aging cream, anti-seborrheic shampoo, microcapsules for the treatment of atherosclerosis, anti-acne niosomal gel technology, and was awarded Azerbaijan and Eurasian patents (2017). -2022).

    Since 2020, Mehraliyeva Sevil Jabrail has been working on her doctoral dissertation on the topic "Development of technology for obtaining nano-forms of medicine based on raw materials of natural origin".

    According to the subject of his doctoral dissertation, he developed the technology of extraction from deer antlers grown in Azerbaijan for the first time. The technology of obtaining nanocapsules for the treatment of Alzheimer's, nanoemulsion and nanogel for the treatment of osteoporosis on the basis of this extract and the acquisition of an Azerbaijani patent in this field belong to Sevil Mehraliyeva (2021-2024).

    In 2023-24, Sevil Mehraliyeva carried out the method of separating the actinide enzyme, which accelerates the digestion process, from the Chinese actinidia fruits grown in Azerbaijan and the microencapsulation of this enzyme.

    Sevil Mehraliyeva also performed the technology of separating rutin from Japanese sophora buds and hop cones and preparing phytosomes based on rutin. Based on these phytosomes, the preparation of phytosomal gel with an effective effect in the treatment of periodontitis and the study of quality criteria were performed by Sevil Mehraliyeva (2024).

    Research Interests: pharmaceutical technology, phyto- and animal medicinal technology, nanotechnology, nanocosmetology, nano- and micropharmaceutical medicinals, biopolymer technology, new drug delivery systems, including stomatological drug delivery systems.

    More Info.
    Priyanka S. Bhatt
    Department of Pharmaceutical Science
    University of South Florida
    USA
    psbhatt@health.usf.edu
    IJPSDR
    More Info.
    J. WARREN SALMON
    Professor
    Pharmacy
    University of Illinois
    USA
    JSJWSalmon@GMAIL.COM
    IJPSDR

    J. Warren Salmon, Ph.D. is Professor of Health Policy and Administration, School of Public Health at the University of Illinois at Chicago (UIC). He was formerly a Professor in and Head of the Department of Pharmacy Administration, College of Pharmacy; Professor of Public Policy Analysis, College of Urban Planning and Public Affairs; and Professor of Medical Education, College of Medicine at UIC.  Professor Salmon's research interests have focused on the corporatization of medicine and pharmacy, managed care pharmacy, urban health care delivery, comparative health care systems, global pharmaceutical industry developments, alternative and complimentary medicines, and selected health policy issues.  He edited Alternative Medicines:  Popular and Policy Perspectives (Tavistock/Methuen/Routledge, 1984); (with Jeffrey W. Todd) The Corporatization of Health Care: A Two Day Symposium and Public Hearing (Illinois Public Health Association, 1988); (with Eberhard Goepel) Community Participation and Empowerment Strategies in Health Promotion, 7 volumes (Zentrum fuer Interdisziplinare Forschung, 1990); The Corporate Transformation of Health Care, Part I:  Issues and Directions (Baywood, 1990); The Corporate Transformation of Health Care, Part II:  Reflections and Implications (Baywood, 1994); and (with Linda Shapiro) Health Care for Chicagoans:  How Will Health System Integration Affect the Health of the Public?  (Health & Medicine Policy Research Group, 1995).

    Research Interest: Health policy and planning; managed care pharmacy; urban health care; international health; pharmaceutical industry developments; community health promotion; public sector health services; corporatization of medicine and pharmacy.

    List of Publications:

    1.    Salmon, J.W. (2015). Time to revisit Medicare Part D?  American Health & Drug Benefits.  
    2.    Salmon, J.W. & Liu, X. M. (2015, in review). Pervasive Stigma:  HIV/AIDS Epidemic in China.  International Journal of Health Services.
    3.    Edlavitch, S.A. & Salmon, J.W. (2015). Towards an applied science of regulatory decision-making. Journal of Pharmacovigilance 3:2.
    4.    Thompson, S.L. & Salmon, J.W. (2016, Book in preparation).  Corporatization:  The Medical Malpractice Insurance Crisis and the Loss of Physician Hegemony. 
    5.    Sanchez, A.M.  & Salmon, J.W.  (2016, in preparation).  Evaluation of the pharmaceutical performance in the undertaking of professional functions in the Cuban health care sector. Journal of Managed Care Pharmacy.
    6.    Thompson, S.L. & Salmon, J.W. (2016, in preparation).  The medical malpractice insurance crisis. International Journal of Health Services
    7.    Salmon, J.W. & Aruru, M.V. (2016, in preparation).  Health Tourism to India: Challenges against resource competition to sustaining a viable public healthcare infrastructure for the local populace.  International Journal of Health Services
    8.    Aruru, M.V., Salmon, J.W. & Brock, C.M. (2016, in review).  Development of the Pharmacy Inventory, Labeling, and Logistics (PILL) Project in Resource-poor Haiti. International Journal of Health Services
    9.    Salmon, J.W. (2016, in preparation).  The global pharmaceutical industry confronts the 21st century.  International Journal of Health Planning & Management.
    10.    Sanchez, A.M.  & Salmon, J.W.  (2014, in revision).  Cuban pharmacy as it transitions toward a pharmaceutical care model.  International Journal of Pharmacy Practice
    11.    Salmon, J.W. (2014). Global Health Systems.  Journal of Pharmacovigilance. 2:3
    12.    Salmon, J.W. & Aruru, M. (2016, in revision).  Privatization and health/medical tourism in their global trade context.  International Journal of Public Policy
    13.    Thompson, S.L. & Salmon, J.W. (2014). Physician Strikes. Chest: Official Publication of the American College of Chest Physicians. November.
    14.    Salmon, J.W. & Gutkin, D. (2015, in preparation). Japan’s pharmaceutical industry: New developments as it challenges the major global firms. Journal of Managed Care Pharmacy.
    15.    Aruru, M., Salmon, J.W. & Douglas, G.W. (2014). Multiple Sclerosis in India: A qualitative study of access, adherence and other issues in Southern India. Proceedings of the Business and Health Administration Association, Chicago, Illinois, March.
    16.    Aruru, M. & Salmon, J.W. (2014). Lessons learned from the Pharmacy pictogram labeling project in Haiti.  Proceedings of the Business and Health Administration Association, Chicago, Illinois, March.
    17.    Salmon, J.W. (2013). Medicare Part D & the Federal Employees Benefit Program. American Health & Drug Benefits.   6(1):58.
    18.    Salmon, J.W. & Jiang, R. (2013). E-Prescribing: History, Issues, and Potentials. Online Journal of Public Health Informatics 4(3).
    19.    Aruru, M. V. & Salmon, J.W. (2013). Assessment of Medicare Part D communications to beneficiaries. American Health & Drug Benefits.  3(5):310-317.
    20.    Qato, D., Salmon, J.W. & Lindau, S.T. (2015, in preparation). Racial and ethnic disparities in the use of prescription medications among older adults in the U.S.:  A Population-based approach. 
    21.    Salmon, J.W. & Sanchez, A.M. (2012). Overview of Complementary/Alternative Medicine in the Cuban Health System, International Journal of Healing and Caring 13(1).
    22.    Sanchez, A.M.  & Salmon, J.W.  (2012). Cuban pharmacy in the context of its healthcare system:  Transitioning toward pharmaceutical care practice.  Proceedings of the Business and Health Administration Association, Chicago, Illinois, March.
    23.    Salmon, J.W. (2016, in preparation). Obamacare:  The dehiscence of the American health care delivery system.
    24.    Salmon, J.W. (2014, in preparation).  Rising Social Epidemics: Avian flu, SARS & AIDS:  Confronting the infrastructural deficiencies of the public health system in China.  International Journal of Health Services.
    25.    Aruru M, & Salmon J W. (2015, in preparation).   Unrestricted and Uninhibited UV exposure: A case for effective policy standards over the Indoor Tanning Industry.   American Journal of Public Health


    More Info.
    BEATA SARECKA-HUJAR
    phd
    Department of Pharmaceutical Technology
    Medical University of Silesia in Katowice
    Poland
    beatasarecka@poczta.onet.pl
    IJPSDR

    After graduation I started to work at Medical University of Silesia, where I completed my PhD thesis on genetic polymorphisms in coronary artery disease. Selected risk factors for development of arterial ischemic stroke in children were also in the area of my scientific interests. Besides, I am also interested in diagnosis and treatment of other neurological disorders in children: schizencephaly, headache, epilepsy and cerebral palsy. Nine years ago, when I moved to the Department of Pharmaceutical Technology I started the research concerning the technology for the manufacturing and optimization of micro- and nanocarriers of active substances. In addition, I am involved in analyses of rheological parameters of semi-solid preparations.


    Research Interest: developmental neurology, neuroscience, genetics, pharmaceutical technology, nanotechnology, biochemistry

    Grants: I participated in a multi-center Polish scientific grant and in several academic grants. In 2017, I was a supervisor of a grant of Medical University of Silesia regarding the release of active substances from semi-solid bases.


    List of Publications:
    Selected articles of my authorship:
    1. Beata Sarecka-Hujar, Ilona Kopyta. Poststroke epilepsy: current perspectives on diagnosis and treatment. Neuropsychiatr.Dis.Treat. 2019; Vol.15, p.95-103

    2. Joanna Sordyl, Ilona Kopyta, Beata Sarecka-Hujar, Tomasz Francuz, Paweł Matusik, Ewa Małecka-Tendera. Lipid levels and selected biomarkers of vascular changes in children with idiopathic headaches - a preliminary report. Arch.Med.Sci. 2019; Vol.15, No.1, p.120-125

    3. Beata Sarecka-Hujar, Andrzej Jankowski, Aneta Ostróżka-Cieślik, Radosław Balwierz, Anna Banyś, Renata Dyja, Dariusz Łukowiec, Dominik Marciniak, Janusz Pluta. Assessment of release of trimetazidine hydrochloride from orally disintegrating tablets (ODTs) prepared using different disintegrants. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.3, p.697-704

    4. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar, Tomasz Krzykawski, Jagna Karcz, Anna Banyś, Andrzej Jankowski. Application of selected diffractive and microscopic methods to evaluate the physical state of drug and morphology of microspheres obtained by spray drying of furosemide with Eudragit L30 D-55. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.3, p.759-765

    5. Beata Sarecka-Hujar, Ilona Kopyta, Michał Skrzypek. Is the 1298A>C polymorphism in the MTHFR gene a risk factor for arterial ischaemic stroke in children? The results of meta.analysis. Clin.Exp.Med. 2018; Vol.18, No.3, p.337-345. 

    6. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar, Andrzej Jankowski. Physicochemical characteristics of furosemide incorporated Eudragit microspheres formulated by spray drying. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.6, p.1369-1376

    7. Beata Sarecka-Hujar, Radosław Balwierz, Aneta Ostróżka-Cieślik, Renata Dyja, Dariusz Łukowiec, Andrzej Jankowski. Scanning electron microscopy and X-ray energy dispersive spectroscopy - useful tools in the analysis of pharmaceutical products. J.Phys.: Conf.Series 2017; Vol.931, 012008, p.1-5

    8. Andrzej Jankowski, Renata Dyja, Beata Sarecka-Hujar. Dermal and transdermal delivery of active substances from semisolid bases. Indian J.Pharmaceut.Sci. 2017; Vol.79, No.4, p.488-500

    9. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar. The use of nanotechnology in modern pharmacotherapy. In: Multifunctional systems for combined delivery, biosensing and diagnostics. / Editors: Alexandru Mihai Grumezescu, Amsterdam: Elsevier Inc., 2017, p. 139-158, ISBN: 978-0-323-52725-5

    10. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar. Perspectives of the carbon nanoparticles use in cancer therapy and imaging. Post.Biol.Kom. 2017; T.44, nr 2, s.171-184

    11. Dorota Raczkiewicz, Beata Sarecka-Hujar, Alfred Owoc, Iwona Bojar. Cognitive functions and serum cortisol concentration in perimenopausal and postmenopausal women working non-manually. Neuroendocrinol.Lett. 2017; Vol.38, No.4, p.269-274

    12. Dorota Raczkiewicz, Alfred Owoc, Beata Sarecka-Hujar, Iwona Bojar. Pain involving the motor system and serum vitamin D concentration in postmenopausal women working in agriculture. Ann.Agric.Environ.Med. 2017; Vol.24, No.1, p.151-155

    13. Beata Sarecka-Hujar, Ilona Kopyta, Michał Skrzypek, J. Sordyl. Association between the 20210G>A prothrombin gene polymorphism and arterial ischemic stroke in children and young adults - two meta-analyses of 3586 cases and 6440 control subjects in total. Pediatr.Neurol. 2017; Vol.69, p.93-101

    14. Beata Sarecka-Hujar, Aneta Ostróżka-Cieślik, Anna Banyś. Determinants of telemedicine development in health care system. Ann.Acad.Med.Siles. 2016; Vol.70, s.214-219

    15. Ilona Kopyta, Paweł Niemiec, Anna Balcerzyk, Ewa Emich-Widera, Ewa Pilarska, Karolina Pienczk-Recławowicz, Marek Kaciński, Janusz Wendorff, Tomasz Nowak, Tomasz Iwanicki, Beata Sarecka-Hujar, Iwona Żak. Fibrinogen alpha and beta gene polymorphisms in pediatric stroke - Case-control and family based study. Eur.J.Paediatr.Neurol.2015; Vol.19, No.2, p.176-180

    16. Ilona Kopyta, Mikołaj Zimny, Beata Sarecka-Hujar. The role of biochemical risk factors in the etiology of AIS in children and adults. Int.J.Neurosci.2015; Vol.125, No.12, p.875-884

    17. Anna Banyś, Beata Sarecka-Hujar, Andrzej Jankowski, Monika Zalewska. Impact of base type on diclofenac sodium release from semi-solid dosage forms. Ann.Acad.Med.Siles. 2014; Vol.68, No.1, s.1-8

    18. Ilona Kopyta, Beata Sarecka-Hujar, Joanna Sordyl, Ryszard Sordyl. The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review. Mol.Biol.Rep. 2014; Vol.41, No.7, p.4241-4251

    19. Beata Sarecka-Hujar, Iwona Żak, Ewa Emich-Widera et al. Association analysis of the E-selectin 98G>T polymorphism and the risk of childhood ischemic stroke. Cell Biochem. Funct. 2010; 28: 591-596.

    20. Ilona Kopyta, Beata Sarecka-Hujar, Ewa Emich-Widera et al. Association between lipids and fibrinogen levels and ischemic stroke in the population of the Polish children with arteriopathy and cardiac disorders. Wiad. Lek. 2010; 63:17-23.  

    21. Zak I, Sarecka-Hujar B, Kopyta I et al. The T allele of the 677C>T polymorphism of methylenetetrahydrofolate reductase gene is associated with an increased risk of ischemic stroke in Polish children. J Child Neurol. 2009; 24: 1262-1267. 

    22. Sarecka-Hujar B, Zak I, Krauze J. Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease. Clin Exp Med. 2009; 9: 117-124.


    More Info.
    Dr. Hitesh Chavda
    Research Scientist
    Formulation and Development, Gowrie Research Pvt Ltd
    HNGU, Patan
    India
    hitesh.chavda@bnsthamelabs.co.uk
    IJPSDR

    Dr. Chavda is dedicated and highly motivated research scientist with more than 13 years of rich Industry-Academic experience. His area of interest is development of formulations including Oral solids, Liquids, Semi-solids, Parenterals and NDDS. He has developed stable and robust formulations across various dosage forms. He has sound understanding of formulation and development using QbD and DOE approaches. He has understanding of product development lifecycle, clinical and regulatory requirements of regulatory bodies like UKMHRA, USFDA etc. There are more than 35 International and National research publications to his credit. In addition to that he has several magazines related articles and Books publications. He is providing editorial service for international journals. He is serving as reviewer at Elsevier, Bentham Sciences, Informa Healthcare, and Wiley Journals.

    List of publications:

    1. Chavda HV*, Neerumalla S, Patel A, Poptani S. Excipients: The Real Players behind Robust

    Formulation. Indian Journal of Pharmaceutical Education and Research. January 2019; 53(1):

    5-7.

    2. Chavda HV*. Artificial Neural Networks in Pharma Product Development. Chronicle

    Pharmabiz. May 2018; 18(23): 42-43.

    3. Chavda HV*. 3D printing: Upcoming revolution for pharmaceutical industry. Chronicle

    Pharmabiz. April 2018; 18(21): 10.

    4. Chavda HV*. Qbd in Developing Topical Dosage Forms. Elyns Journal of Pharmaceutical

    Research December 2016; 2(1): 90000106. [Short Communication]

    5. Chavda HV*. Nanopharmaceuticals: The Pharmaceuticals of Present Era. Elyns Journal of

    Pharmaceutical Research 2016; 1(2): 106e. [Editorial Article]

    6. Chavda HV*, Naik S, Mukhopadhyay P. QbD Concept Implementation for Excipients.

    Ingredients South Asia Magazine. Saffron Media Publication, November, 2016; 11: 119-120.

    7. Chavda HV*. Reforms in Pharmaceutical Education in India. Ingredients South Asia

    Magazine. Saffron Media Publication, April 16-30, 2016; 9(14): 48-51.

    8. Chavda HV*. African Market: Big Window of Opportunity. Ingredients South Asia Magazine.

    Saffron Media Publication, January 16-31, 2016; 9(8): 30-32.

    9. Chavda HV*. SPHs as an Unusual Upcoming Excipient. Ingredients South Asia Magazine.

    Saffron Media Publication, December 1-15, 2015; 9(5): 104-111.

    10. Chavda HV*, Patel RI, Patel CN. Preparation and Characterization of Ternary Solid Dispersion

    of Flunarizine Dihydrochloride. World Journal of Pharmaceutical Research (ISSN: 2277-7105)

    2015; 4(5): 2506-2521.

    11. Chavda HV*, Chavada G, Patel J, Rangpadiya K, Patel CN. Topical Vaginal Drug Delivery

    System Based on Superporous Hydrogel Hybrids. Protein & Peptide Letters (ISSN: 0929-8665,

    Impact Factor 1.735) 2014; 21(11): 1176-1184.

    12. Chavda HV*, Patel RD, Modhia IP, Patel CN. Role of Superporous Hydrogel Particles as a

    Superdisintegrant in Fast Disintegrating Tablet of Glipizide. Chronicles of Young Scientists

    (ISSN: 2229-5186) 2014; 5(1):11-19.

    13. Chavda HV*, Patel J, Chavada G, Dave S, Patel A, Patel CN. Self Nanoemulsifying Powder of

    Isotretinoin: Preparation and Characterization. Journal of Powder Technology. (ISSN: 2090-

    7737) 2013; 2013 Article ID 108569, 9 pages. [Cited on 15/11/2013].

    14. Chavda HV*, Modhia IP, Mehta A, Patel RD, Patel CN. Development of Bioadhesive Chitosan

    Superporous Hydrogel Composite Particles based Intestinal Drug Delivery System. BioMed

    Research International (ISSN: 2314-6133, Impact Factor 2.880) 2013; 2013 Article ID 563651,

    10 pages. [Cited on 06/08/2013]

    Page 7 of 12 Dr. Hitesh Chavda

    15. Chavda HV*, Patel SK, Patel CN. Insignificant Effect of Superporous Hydrogel Particles as a

    Superdisintegrants in Fast Dispersible Tablets of Aceclofenac. Online article PharmaTutor

    (ISSN: 2347 - 7881) 2013 (Published on Web 31/01/2013). Available from:

    http://www.pharmatutor.org/articles/ insignificant-effect-of-superporous-hydrogelparticles-

    as-superdisintegrants-in-fast-dispersible-tablets-of-aceclofenac?page=0,0 [Cited on

    31/01/2013].

    16. Chavda HV*, Patel RD, Modhia IP, Patel CN. Preparation and Characterization of

    Superporous Hydrogel Based on Different Polymers. Int J Pharm Investig (ISSN: 2230-973X)

    2012; 2(3):134-139.

    17. Chavda HV*, Patel MS, Patel CN. Preparation and In Vitro Evaluation of Guar Gum Based

    Triple-Layer Matrix Tablet of Diclofenac Sodium. Res Pharm Sci (ISSN: 1735-5362, Impact

    Factor 0.220) 2012; 7(1): 57-64.

    18. Chavda HV*, Patel CN. Pharmaceutical Formulations for Oral Transmucosal Drug Delivery.

    News Tech 2011; 29:10-11.

    19. Chavda HV*, Patel CN, Modh KM, Panigrahi B. Preparation, Characterization and In Vitro

    Evaluation of Carbopol-based Superporous Hydrogel Composite. Indian J Pharm Sci (ISSN:

    0250-474X, Impact Factor: 0.626) 2011; [Accepted on 12/05/2011].

    20. Chavda HV*, Chaudhari TM, Patel CN. Antacids Incorporation in Immediate Release Tablets

    Failed to Improve the Stability of Omeprazole in Acidic Media. J Pharm Negative Results

    (ISSN: 0976-9234) 2011; 2(2):73-77.

    21. Chavda HV*, Patel CN. Preparation and in vitro evaluation of a stomach specific drug delivery

    system based on superporous hydrogel composite. Indian J Pharm Sci (ISSN: 0250-474X,

    Impact Factor: 0.626) 2011; 73(1):30-37.

    22. Chavda HV*, Patel CN. Effect of Crosslinker Concentration on Characteristics of Superporous

    Hydrogel. Int J Pharm Investig (ISSN: 2230-973X) 2011; 1(1):17-21.

    23. Chavda HV*, Patel CN. A Newer Formulation Approach: Superporous Hydrogel Composite-

    Based Bioadhesive Drug-Delivery System. Asian J Pharm Sci (ISSN: 1818-0876, Impact Factor

    0.250) 2010; 5(6): 239-250.

    24. Chavda HV*, Patel CN. Chitosan Superporous Hydrogel Composite-Based Floating Drug-

    Delivery System: A Newer Formulation Approach. J Pharm Bioall Sci (ISSN: 0976-4879,

    Impact Factor 0.175) 2010; 2(2): 124-131.

    25. Chavda HV*, Patel CN, Prajapati ST, Patel CV. A Newer Formulation Approach Based on

    Superporous Hydrogel Particles for Gastroretentive Drug-Delivery System: Preparation and

    In Vitro Evaluation. Inventi Impact: NDDS (ISSN: 2229-4147) 2010; 2: Article ID: 2010nd70a

    (Published on Web 15/07/2010; www.inventi.in).

    26. Chavda HV*, Patel CN, Prajapati ST, Patel CV. A Newer Formulation Approach Based on

    Superporous Hydrogel Particles for Gastroretentive Drug-Delivery System: Preparation and

    In Vitro Evaluation. Inventi Rapid: NDDS (e-ISSN: 0976-3791) 2010; 1(1): Article ID:

    2010nd70a (Published on Web 13/04/2010; www.inventi.in).

    27. Chavda HV*, Patel CN, Anand IS. Biopharmaceutics Classification System. Syst Rev Pharm

    (ISSN: 0975-8453) 2010; 1(1): 62-69.

    28. Chavda HV*, Patel CN. Preparation and Characterization of Swellable Polymer-based

    Superporous Hydrogel Composite of Poly (Acrylamide-co-Acrylic Acid). Trends Biomater Artif

    Organs (ISSN: 0971-1198, Impact Factor: 0.675) 2010; 24(2): 83-89.

    29. Chavda HV*, Patel CN. Effects of Solvent Treatments on Characteristics of Superporous

    Hydrogels. Ethiopian Pharm J (ISSN: 1029-5933) 2009; 27(1): 16-24.

    30. Chavda HV*, Patel CN, Karen HD. Preparation and Characterization of Chitosan-Based

    Superporous Hydrogel Composite. J Young Pharm (ISSN: 0975-1483) 2009; 1(3): 199-204.

    31. Chavda HV*, Patel CN. Aquaporins: Secret Highways for Water Transport. Pharm Reviews

    (ISSN: 1918-5561) 6(2), Apr 11, 2008.

    Page 8 of 12 Dr. Hitesh Chavda

    32. Chavda HV*, Patel CN, Patel AM, Patel BN. Supercritical Fluid: Green Solvent for Tomorrow.

    Pharm Reviews (ISSN: 1918-5561)5(3), May 16, 2007.

    33. Chavda HV*. Dendrimers: Polymers of 21st Century. Pharm Reviews (ISSN: 1918-5561) 5(1),

    Feb. 02, 2007.

    Co-author:

    34. Modi J*, Patel JK, Chavda HV. Superporous Hydrogel: A Supreme Approach for Gastric

    Retention. Online article PharmaTutor (ISSN: 2347 - 7881) 2012 (Published on Web

    03/08/2012). Available from: http://www.pharmatutor.org/articles/superporous-hydrogela-

    supreme-approach-for-gastric-retention [Cited on 31/01/2013].

    35. Karen HD*, Anand IS, Patel CN, Chavda HV, Patel JK. Formulation and Evaluation of

    Amphotericin-B as A Lyophilized Product. J Global Pharma Tech (ISSN: 0975-8542) 2010;

    2(2): 75-78.

    36. Parikh BN*, Gothi GD, Patel TD, Chavda HV, Patel CN. Microsponge as Novel Topical Drug

    Delivery System. J Global Pharma Tech (ISSN: 0975-8542) 2010; 2(1): 17-29.

    More Info.
    David J Mastropietro
    Assistant Professor
    Nova Southeastern University
    USA
    dmastro1111@gmail.com
    IJPSDR

    Research Interest: Abuse-Deterrent Formulations (Tamper-Resistant Pharmaceutical Dosage Forms) Gastric Retention, Oral Drug Delivery, Controlled Drug Delivery Systems and Technologies, Gels, Hydrogels, Alcogels, Pharmacy Compounding.

    More Info.
    Gitali Indra
    Asst. Professor
    Department of Pharmaceutical Sciences
    Oregon State University
    USA
    indrag@onid.orst.edu
    IJPSDR

    Research Interest: Elucidate the molecular and cellular mechanisms of contribution of hair follicle stem cells in wound repair and regeneration and identify new therapeutic targets toward the goal of accelerating wound healing and to identify natural compounds that are effective against head and neck cancer.

    More Info.
    Anastasios (Tassos) Lymperopoulos
    Assistant Professor
    Pharmacology
    Nova Southeastern University
    USA
    al806@nova.edu
    IJPSDR

    Research Interest: Molecular pharmacology, physiology and biology of G protein-coupled (heptahelical or seven transmembrane-spanning) receptors; Heart Failure; Cardiovascular Disease; Neurohormonal control of the Circulation; Adrenal Physiology and Pharmacology; Receptors for Adrenaline and Noradrenaline; Catecholamines; Receptors for Angiotensin II; Signal Transduction; Gene Therapy; Transgenic mice and rats; Aldosterone production regulation; Regulation of Adrenergic and Angiotensin Receptors; G protein-coupled receptor Kinases; Beta-Arrestins; Novel “Biased” G protein-coupled Receptor Ligands.

    More Info.
    Vijay Kumar Nekkanti
    Research Assistant Professor
    Western University of Health Sciences
    USA
    vnekkanti@westernu.edu
    IJPSDR

    Research Interest: Liposomes, Drug Nanoparticles, Solid Lipid Nanoparticles and Lipid Based Drug Delivery Systems.

    More Info.
    Yike Zou
    Department of Chemistry
    University of Pennsylvania
    USA
    zouyike@sas.upenn.edu
    IJPSDR

    Research Interest: Organic Chemistry: Total Synthesis of Complex Natural Product, Computational Chemistry: Conformational Analysis, Molecular Modelling and Spectra Simulation. Natural Product Discovery: Isolation, Structural Elucidation, and Absolute Configuration Deter-mination of Natural Product.

    More Info.
    Shu-Feng Zhou
    Global Medical Development
    University of South Florida
    USA
    szhou@health.usf.edu
    IJPSDR

    Research Interest: Systems Pharmacology, Drug Metabolism & Drug Transport, Pharmacokinetics/Pharmacometrics, Pharmacogenomics, Nanomedicine and Chinese Medicine.

    More Info.
    Francis Ignatious
    Senior Scientific Investigator
    Glaxo Smith Kline
    USA
    Francis.2.Ignatious@gsk.com
    IJPSDR
    More Info.
    Darshana Jani
    Global Research and Development
    USA
    Darshana.Jani@pfizer.com
    IJPSDR

    Research Interest: Immunogenicity, PK, Biomarker, Regulated and non regulated bioanalysis.

    More Info.
    Fatima Morales Marin
    Medicinal Chemistry, Genetics, Cancer Research
    Temple University
    USA
    fatimamorales@ugr.es
    IJPSDR

    Research Interest: Cancer, CDK inhibitors, Purine Derivatives, Nutrition, Parasitism, Phytotherapy, Molecular Biology, Genetics, Cancer Research, Medicinal Chemistry.

    More Info.
    Mohammed Maniruzzaman
    Researcher
    University of Greenwich
    UK
    M.Maniruzzaman@greenwich.ac.uk
    IJPSDR

    Research Interest: Drug Delivery, Continuous manufacturing, Dissolutions, Solubility, Cocrystalisation, Hot-Melt Extrusion, Particle Engineering, Medical Implants, Solid-State Analysis, PAT, QbD, Spray Drying, Process Engineering.

    More Info.
    Ramune Jacobsen
    Institute of Preventive Medicine Frederiksberg Hospital
    Denmark
    ramune.jacobsen@regionh.dk
    IJPSDR

    Research Interest: Outcomes of interventions in public health (health promotion, health services and disease, prevention).

    More Info.
    Sara Malo
    Department of Microbiology, Medicine
    University of Zaragoza
    Spain
    smalo@unizar.es
    IJPSDR

    Research Interest: Pharmacoepidemiology, Drug utilization and factors related, Appropriateness, Adherence to clinical guidelines, Effectiveness, Variability.

    More Info.
    Wei-Gang Hu
    Bio-Threat Defence Section
    DRDC Suffield Research Centre
    Canada
    Wei-Gang.Hu@drdc-rddc.gc.ca
    IJPSDR

    Research Interest: Molecular Biology, Immunology (antibodies, vaccines), and Microbiology (viruses, bacteria, and toxins).

    More Info.
    Agata Paneth
    Department of Organic Chemistry
    Medical University of Lublin
    Poland
    agata.paneth@umlub.pl
    IJPSDR

    Research Interest: Medicinal chemistry, Structure-activity relationship studies, Synthesis of heterocyclic compounds, Antimicrobial screening, Enzymatic studies.


    More Info.
    Agnieszka Bialek
    Biology, Chemistry, Medicine
    Medical University of Warsaw
    Poland
    agnieszka.bialek@wum.edu.pl
    IJPSDR

    Research Interest: Effects of different diets, Dietary factors and fatty acids (especially conjugated fatty acids) on health, Especially on the Cancer Risk.

    More Info.
    Fenfei Gao
    Professor
    Department of Pharmacology
    Shantou University Medical College
    China
    ffgao@stu.edu.cn
    IJPSDR

    Research Interest: Ion channel and electrophysiology, Neuropharmacology, Chinese medicinal herbs.


    More Info.
    Wanying Wu
    Professor
    Shanghai Institute of Materia Medica Chinese Institute of Science
    China
    wanyingwu@simm.ac.cn
    IJPSDR

    Research Interest: Molecular Biology, Biotechnology Genetics, Analytical Chemistry.


    More Info.
    Hongyuan Yan
    Professor
    Hebei University
    China
    yanhy@hbu.edu.cn
    IJPSDR

    Research Interest: Separation & purification and quality control of food science; new functional materials for food and pharmaceutical analysis.


    More Info.
    Hong-Tao Xiao
    Professor
    Department of Pharmacy Sichuan Provincial Peoples Hospital
    China
    xht927@163.com
    IJPSDR

    Research Interest: Experimental and clinical pharmacology about natural product, Pharmacokinetics of  medicinal plant.


    More Info.
    Xiao-Hui Wu
    Associate Professor
    Tianjin Medical University
    China
    longhui804@163.com
    IJPSDR

    Research Interest: Natural products chemistry (including extraction and separation of compounds and structure elucidation), Discovery and biological investigation of novel drug lead compounds from plant and microbial biodiversity, Botanical dietary supplements and functional foods research and evaluation of natural product-based botanical medicines, Quality control, pharmacokinetics and in vivo metabolism of Traditional Chinese Medicine.


    More Info.
    Cui Yang
    Ethnic Drug Screening and Pharmacology Center
    Yunnan Minzu University
    China
    yangynni@163.com
    IJPSDR

    Research Interest: Cardiovascular pharmacology, New Therapeutic targets for atherosclerosis, hypertension and vasculogenesis, Screening of TCM and ethnic drugs.


    More Info.
    Tomasz Plech
    Department of Organic Chemistry
    Medical University of Lublin
    Poland
    tomasz.plech@umlub.pl
    IJPSDR

    Research Interest: Synthesis of nitrogen- and sulfur-containng heterocycles, Design and synthesis of Novel anticonvulsant, Anticancer, Antibacterial and anti-toxoplasmosis drugs, Computer-aided drug Design, Chromatographic techniques for the analysis of the newly ynthesized compounds, (Q)SAR sudies.


    More Info.
    Thierry Vandamme
    Professor
    University of Strasbourg
    Belgium
    vandamme@unistra.fr
    IJPSDR

    Research Interest: Medicine, Pharmacology, Pharmacy, Cell Culture,Genetic Engineering, Medicinal and Pharmaceutical Chemistry, Medical Neurosciences, Pharmaceutical Development.

    More Info.
    Amanj Baker
    Researcher
    Medicines and Health
    University of Nottingham
    UK
    paxaib@nottingham.ac
    IJPSDR

    Research Interest: Drug utilisation, Public Health, Cardiology, Diabetology.

    More Info.
    Jing Tang
    Associate Professor
    Shanghai Jiao Tong University
    China
    angel_tj99@126.com
    IJPSDR

    Research Interest: Antibiotics, Virus, Infected Diseases, Drug–Drug Interactions.


    More Info.
    Weien Yuan
    Associate Professor
    School of Pharmacy
    Shanghai Jiao Tong University
    China
    yuanweien@126.com
    IJPSDR

    Research Interest: Nanomedicines for therapy Parkinson's disease, Alzheimer’s disease and neural Tissue repair.


    More Info.
    Carmela Saturnino
    Associate Professor
    Medicinal Chemistry and Toxicology
    University of Salerno
    Italy
    saturnino@unisa.it
    IJPSDR

    Research Interest: QSAR, Medicinal Chemistry, Organic Synthesis, Cytotoxicity, Heterocyclic Compounds, Synthesis, Synthesis of Organic Molecules, Pharmaceutical Development, Antioxidant Activity, Mutagenicity.

    More Info.
    Nicola Micale
    Full professor
    Department of Chemical, Biological, Pharmaceutical and Environmental Sciences
    University of Messina
    Italy
    nmicale@unime.it
    IJPSDR

    Research Interest: Design, Synthesis and qualitative SAR of new anticonvulsant agents acting as non-competitive AMPA receptor antagonists (In collaboration with Dr. Li Niu, Chemistry Department, University at Albany, SUNY, Albany NY), Identifications and synthesis of new anti-cancer agents, Design and synthesis of peptidomimetics as protease inhibitors.

    More Info.
    Mahmud Kajbaf
    Senior Research Scientist
    Drug Metabolism, Division of Aptuit
    Italy
    mahmud.kajbaf@aptuit.com
    IJPSDR

    Research Interest: Drug Metaboilism, Mass spectrometry, Pharmacokinetics and Pharmacodynamics, Medicine, Pharmacy.

    More Info.
    Francesca Borrelli
    Department of Pharmacy
    University of Naples Federico II
    Italy
    franborr@unina.it
    IJPSDR

    Research Interest: Therapeutic relevance of plant-derived compounds in the field of the gastrointestinal pathologies (IBD, cancer, etc.) and on the signal transduction mechanisms involved in their action.Moreover, Toxicological aspects of natural products are also studied.

    More Info.
    Francesco Maione
    Department of Pharmacy
    University of Naples Federico II
    Italy
    francesco.maione@unina.it
    IJPSDR

    Research Interest: Inflammation, Immunopharmacology, Pharmacology of Natural Products/Compounds.

    More Info.
    Antonio Randazzo
    Associate Professor
    Medicinal Chemistry
    University of Naples Federico II
    Italy
    antonio.randazzo@unina.it
    IJPSDR

    Research Interest: Organic & Biomolecular Chemistry, Department of Pharmacy.

    More Info.
    Waseem Kaialy
    Science and Engineering
    University of Wolverhampton
    UK
    w.kaialy@wlv.ac.uk
    IJPSDR

    Research Interest: Pharmaceutics, Pharmaceutical Sciences, Drugdelivery, Inhalation, Dosage forms, Particle engineering.

    More Info.
    Chunlin Zhuang
    School of Pharmacy
    Second Military Medical University
    China
    zclnathan@163.com
    IJPSDR

    Research Interest: Discovery and development of novel protein-protein interaction inhibitors of the Tumorigenic process,Spectrum of drug discovery efforts combining computer-aided drug design, lead Generation, SAR design, Organic Synthesis, Biochemical Assays, Cell Culture Assays and Pharmacology.

    More Info.
    Lei Wang
    School of Pharmacy
    Queen s University Belfast
    UK
    l.wang@qub.ac.uk
    IJPSDR

    Research Interest: Natural drug discovery, Isolation, Physiological and pharmacological characterization of venom/toxin peptides and proteinswith animal tissues, Natural peptides and proteins analytical Chemistry, Mass spectrometry analysis, Molecular biology, Synthetic peptide analogues and their interaction with antibodies and receptors, Identification of novel drug targets, Biomarkers, Ion channel.

    More Info.
    Kai Xiao
    Associate Professor
    West China Hospital
    Sichuan University
    China
    iamxiaokai@hotmail.com
    IJPSDR

    Research Interest: Pharmacology & Toxicology, Experimental Pharmacology, Toxicology.

    More Info.
    Xiaodong Zheng
    Department of Pathophysiology
    Harbin Medical University
    China
    xzheng2001@163.com
    IJPSDR

    Research Interest: Ophthalmology, Cataract Surger,Cornea, Refractive Eye Surgery, Keratoconus.


    More Info.
    Dong-Soon Im
    Professor
    College of Pharmacy
    Pusan National University
    South Korea
    imds@pusan.ac.kr
    IJPSDR

    Research Interest: G-protein coupled receptors for lipid mediators, Molecular and cellular functions of lipid mediators.

    More Info.
    Gilson Khang
    Chonbuk National University
    South Korea
    gskhang@jbnu.ac.kr
    IJPSDR

    Research Interest: Biotechnology, Artificial Intelligence, Neuroscience, Stem Cell Biology, Tissue Engineering, Stem Cell, Regenerative Medicine, Biodegradation.

    More Info.
    Nergiz Hacer Turgut
    Associate Professor
    Department of Pharmacology
    Katip Celebi University
    Turkey
    nergizht@yahoo.com
    IJPSDR

    Research Interest: Antioxidants and free radicals, Cardiovascular Pharmacology, Behavioral tests, Cell culture and cancer research, Pulmonary Pharmacology.

    More Info.
    Ruofeng Shang
    Lanzhou Institute of Husbandry and Pharmaceutical Sciences
    China
    shangrf1974@163
    IJPSDR

    Research Interest: Medicinal Chemistry, Medicinal and Pharmaceutical Chemistry.


    More Info.
    Tanveer A Wani
    Department of Pharmaceutical Chemistry
    King Saud University
    Saudi Arabia
    twani@ksu.edu
    IJPSDR

    Research Interest: Method development and validation of biosensors for estimation of Cancer Markers.

    More Info.
    Assem Mahmoud Eelsayed Barakat
    Assistant Professor
    Organic Chemistry
    King Saud University
    Saudi Arabia
    ambarakat@ksu.edu.sa
    IJPSDR

    Research Interest: Green Chemistry, Development of new catalytic asymmetric methodologies, Development of new green synthetic methodologies for desired target molecule, Development and synthesis of chiral reagents, metal catalysts in asymmetric synthesis to synthesize novel bioactive compounds, Design and synthesis of heterocycle derivatives as potential pharmaceuticals in medicine, X-Ray diffraction for elucidation the chemical structures of organic compounds.

    More Info.
    Wei Wang
    Professor
    School of Pharmacy
    Hunan University of Chinese Medicine
    China
    wangwei402@hotmail.com
    IJPSDR

    Research Interest: Isolation and structure elucidation of natural products, Search for bioactive compounds, Antifungal, Anticancer and anti-inflammatory phytochemicals from traditional Chinese medicine (TCM) or other ethnic medicine (e.g. Tujia, Miao and so on);Chemical and pharmacological study of Chinese medicine; Quality control study of Chinese medicine.

    More Info.
    Nian-Qiu Shi
    Department of Pharmaceutics School of Pharmacy Ji Lin Medical College
    China
    shinianqiu2009@163.com
    IJPSDR

    Research Interest: Targeting drug delivery systems (TDDS), Multifunctional nanocarriers or macromolecules have many advantages for diseases treatments. Our lab employs diverse targeting delivery systems including conjugate, liposomes and micelles to deliver anticancer drug or gene for tumor therapy. In this process, we unitize stimuli-responsive strategies (e.g. enzyme-responsive) to obtain the targeting therapy of tumor. Cell-penetrating peptides (CPPs) are also adopted to cross cellular barriers. Internalization mechinisms of CPPs or CPP-cargoes are also focused by us.

    More Info.
    Dou De-Qiang
    Department of Natural Products Chemistry
    Liaoning University of Traditional Chinese Medicine
    China
    deqiangdou@126.com
    IJPSDR

    Research Interest: Bioactive constituents from natural resources, Quality control methods of natural medicines, Anaphylactoid constituents of herbal injections, R&D of new natural medicines.

    More Info.
    Qiusheng Zheng
    Binzhou Medical University
    China
    zqsyt@sohu.com
    IJPSDR

    Research Interest: Reactive Oxygen Species, Apoptosis, Signaling Pathways, Western Blot, Phosphorylation, Superoxide Dismutase, NADPH Oxidase, Monocytes

    More Info.
    Mohammad-Ali Shahbazi
    Division of Pharmaceutical Technology
    University of Helsinki
    Finland
    m.a.shahbazi@helsinki.fi
    IJPSDR

    Research Interest: Biomaterials, Nanomedicine, Pharmaceutical Nanotechnology, Nanovaccines, Targeted drug delivery, Nanotoxicity, surface biofunctionalization, Cell-nanoparticle Interactions.

    More Info.
    Mafalda Ascensao Videira
    Assistant Professor
    Department of Pharmaceutics
    University of Lisbon
    Portugal
    mvideira@ff.ul.pt
    IJPSDR

    Research Interest: Cancer Diagnostics, Cancer Research, Clinical Trials, Ophthalmology, Business, Economic Genetics, Stem Cell Biology, Cell Biology, Translational Cancer Research, Business Ethics, Oncology, Molecular Biology.

    More Info.
    Ana Maria Loureiro da Seca
    University of the Azores
    Portugal
    anaseca@uac.pt
    IJPSDR

    Research Interest: Phytochemistry, Natural products, Isolation of Natural Compounds, Structural Elucidation, Chromatographic Techniques, Bioactive Secondary Metabolites.

    More Info.
    Dolores Remedios Serrano Lopez
    Researcher
    School of Pharmacy and Pharmaceutical Sciences
    Ireland
    serranod@tcd.ie
    IJPSDR

    Research Interest: P8 Advancing conventional solid dosage formulation and processing.

    More Info.
    Rafik Bachoual
    Professor
    Microbiology and Immunology
    University of Gabes
    Tunisia
    rbachoual@yahoo.com
    IJPSDR

    Research Interest: Microbiology and Immunology, Antibiotic mechanism of Action and resistance, Inflammation and Natural Antiinflamatory Products.

    More Info.
    Daniela Benedec
    Department of Pharmacognosy
    Iuliu Hatieganu University of Medicine and Pharmacy
    Romania
    dani_67ro@yahoo.com
    IJPSDR

    Research Interest: Natural Product Chemistry,Nanotechnology, Essential Oils, Nanobiotechnology, Antioxidants,Veterinary Medicine, Dermatology, Pharmacy, Medicinal and Pharmaceutical Chemistry, Thin Films and Nanotechnology, Medicinal Plants and Herbs, Plant Biotechnology, Antioxidant Activit, Polyphenols, Phenolic Compoun, DPP, Botan, Microbiology, Environmental Chemistry, Antioxidant Assays, Flavonoids, Biotechnology, Bioactivi, Phytochemicals,LC-MS, Medicinal Plants, Spectroscopy, Chromatography, Natural Products, Ethnomedicine, Natural Product Isolatio.

    More Info.
    Hanganu Daniela
    Associate Professor
    Department of Pharmacognosy
    University of Medicine and Pharmacy Cluj-Napoca
    Romania
    handa_1964@yahoo.com
    IJPSDR

    Research Interest: Medicinal Plants, Obtaining, Characterization and standardization of extracts, Testing their pharmacological Action, Testing antioxidant activity in vitro and in vivo, Analysis and  isolation of biologically active compounds (polyphenols, carotenoides, essential oils, terpenes, alkaloids), spectrometric and chromatographical analysis (HPLC, GC).

    More Info.
    Raita Laura Oana
    Raita Laura Oana National Institute for Research and Development Isotopic and Molecular Technologies
    Romania
    oana.raita@itim-cj.ro
    IJPSDR

    Research Interest: Expression Microarrays, Next Generation Sequencin, Liquid Handling Robotics, cDNA Synthesis, RNA Isolation, Splicing, PCR, Gene Expressio, Cell Cultur, Molecular Cloning, Regulation of Gene Expression, RNA Biology, Transcriptomics, Gel Electrophoresis, RNA Splicing.

    More Info.
    Eleftherios Pelechas
    Epidemiology
    Grigore T. Popa University of Medicine and Pharmacy
    Romania
    pelehas@yahoo.com
    IJPSDR

    Research Interest: Epidemiology, Health Management and Rheumatology.

    More Info.
    Wen-Huang Peng
    College of Pharmacy
    China Medical University
    Taiwan
    whpeng@mail.cmu.edu.tw
    IJPSDR

    Research Interest: Pharmacology on Chinese Herb, Cognitive Pharmacology on Chinese Herb, Behavioral Pharmacology, Psychopharmacology, Neuropharmacology.

    More Info.

    Indexing/Archiving